Association between lithium treatment and renal, thyroid and parathyroid function: A cohort study of 6659 patients with bipolar disorder
Bipolar Disorders · 2024-02 · 26 (1) · 71-83
DOI: 10.1111/bdi.13356 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Bipolar Disorders, online erschienen am 10.06.2023. Verfasst von Anne Christine Wiuff und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Affective Disorders, Aarhus University Hospital-Psychiatry, Aarhus, Denmark. Hauptthemen laut MEDLINE: Bipolar Disorder, Parathyroid Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Although potential adverse effects of lithium treatment on renal and endocrine systems have been extensively investigated, most prior studies are limited by selected populations and short follow‐up.
Methods
Within the Psychiatric Services of the Central Denmark Region, we identified all patients with bipolar disorder and ≥1 serum‐lithium (se‐Li) measurements between January 1, 2013, and July 20, 2022, and reference patients with bipolar disorder matched on age, sex, and baseline creatinine. Outcomes were diagnoses of renal, thyroid and parathyroid disease, and blood tests measuring creatinine, estimated glomerular filtration rate (eGFR), thyroid‐stimulating hormone (TSH), parathyroid hormone (PTH) and calcium. Analyses included unadjusted multilevel regression to describe changes in biochemical markers, and adjusted Cox regression to compare rates of disease/biochemical outcomes between lithium users and reference patients.
Results
Among 1646 lithium users (median age 36 years, 63% women) and 5013 reference patients, lithium users had decreasing TSH and eGFR, stable PTH, and increasing calcium levels over time. Lithium use was associated with increased rates of renal, thyroid and parathyroid disease, and levels of biochemical markers outside normal ranges (hazard rate ratios: 1.07–11.22), but the absolute number of severe outcomes was low (e.g., chronic kidney disease: N = 10, 0.6%). Notably, the rate of blood testing was substantially higher among lithium users than among reference patients (e.g., mean number of creatinine tests during the second year of follow‐up: lithium users = 2.5, reference patients = 1.4).
Conclusions
Severely adverse renal and endocrine outcomes are rare during lithium treatment. Observational studies of long‐term lithium treatment are prone to detection bias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Affective Disorders, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Dauten Family Center for Bipolar Treatment Innovation, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.
ORCID-Profile: Anne Christine Wiuff, Christopher Rohde, Andrew A Nierenberg, Søren Dinesen Østergaard, Ole Köhler-Forsberg
Zitieren
APA
Wiuff, A. C., Rohde, C., Jensen, B. D., Nierenberg, A. A., Østergaard, S. D., & Köhler-Forsberg, O. (2024). Association between lithium treatment and renal, thyroid and parathyroid function: A cohort study of 6659 patients with bipolar disorder. Bipolar Disorders, 26(1), 71-83. https://doi.org/10.1111/bdi.13356
Vancouver
Wiuff AC, Rohde C, Jensen BD, Nierenberg AA, Østergaard SD, Köhler-Forsberg O. Association between lithium treatment and renal, thyroid and parathyroid function: A cohort study of 6659 patients with bipolar disorder. Bipolar Disorders. 2024;26(1):71-83. doi:10.1111/bdi.13356
BibTeX
@article{Wiuff2024,
author = {Wiuff, Anne Christine and Rohde, Christopher and Jensen, Botilla Dalsgaard and Nierenberg, Andrew A and Østergaard, Søren Dinesen and Köhler-Forsberg, Ole},
title = {Association between lithium treatment and renal, thyroid and parathyroid function: A cohort study of 6659 patients with bipolar disorder},
journal = {Bipolar Disorders},
year = {2024},
volume = {26},
number = {1},
pages = {71--83},
doi = {10.1111/bdi.13356}
}
EUVIMED